MID2 and breast carcinoma: In breast cancer, TRIM1 expression has been reported to be up-regulated via MORC4/STAT3-mediated transcription activation, which might be the reason that leaded to circTRIM1 overexpression in chemoresistant TNBC cells and tissues [54].